Research News and Research

RSS
Medicare costs rise as hospice use increases

Medicare costs rise as hospice use increases

Health insurers defend rate increases

Health insurers defend rate increases

UV light exposure and vitamin D play a potential role in chronic digestive conditions

UV light exposure and vitamin D play a potential role in chronic digestive conditions

Vegenics receives IND approval from FDA for VGX-100 Phase I study in late stage cancers

Vegenics receives IND approval from FDA for VGX-100 Phase I study in late stage cancers

Political cartoon: 'Great Pumpkin'

Political cartoon: 'Great Pumpkin'

J&JPRD submits NUCYNTA ER sNDA to FDA for DPN associated neuropathic pain

J&JPRD submits NUCYNTA ER sNDA to FDA for DPN associated neuropathic pain

Infinity commences two IPI-145 Phase 1 clinical trials for hematologic malignancies

Infinity commences two IPI-145 Phase 1 clinical trials for hematologic malignancies

First Edition: October 31, 2011

First Edition: October 31, 2011

Avanir seeks EMA marketing authorization for NUEDEXTA to treat pseudobulbar affect

Avanir seeks EMA marketing authorization for NUEDEXTA to treat pseudobulbar affect

AgonOx, MedImmune partner to advance OX40 agonist programs for cancer treatment

AgonOx, MedImmune partner to advance OX40 agonist programs for cancer treatment

Auxilium reports net revenues of $66.7 million for third quarter 2011

Auxilium reports net revenues of $66.7 million for third quarter 2011

PPRT publishes study that evaluates pharmacist provision of clozapine

PPRT publishes study that evaluates pharmacist provision of clozapine

GC-C agonists have potential to delay progression of colitis into colon cancer

GC-C agonists have potential to delay progression of colitis into colon cancer

Pacira's third quarter total revenues decrease to $4.0 million

Pacira's third quarter total revenues decrease to $4.0 million

Fierce Vaccines highlights Inovio's VGX-3100 as one of 10 Promising Therapeutic Vaccines

Fierce Vaccines highlights Inovio's VGX-3100 as one of 10 Promising Therapeutic Vaccines

Hercules Pharma granted rights to license 22nd Century's X-22 smoking cessation aid

Hercules Pharma granted rights to license 22nd Century's X-22 smoking cessation aid

EarlySense to launch contact-free patient monitoring system in Europe

EarlySense to launch contact-free patient monitoring system in Europe

NALC's national bowling event to raise money for Muscular Dystrophy Association

NALC's national bowling event to raise money for Muscular Dystrophy Association

Mayo Clinic, Oxford BioMedica collaborate to develop gene therapy for glaucoma

Mayo Clinic, Oxford BioMedica collaborate to develop gene therapy for glaucoma

Study: New verbal autopsy methods are fast, effective and inexpensive

Study: New verbal autopsy methods are fast, effective and inexpensive

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.